The potentiating effect of genistein on the relaxation induced by isoproterenol in rat aortic rings

General Pharmacology

Volumn 33, Issue 3, 1999, Pages 221-227

  Satake, N ^a   Shibata, S ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

Cytochrome P 450; Genistein; Isoproterenol; K(Ca) channels; Phosphodiesterase; Rat aortic rings; Relaxation

Indexed keywords

ALPHA NAPHTHOFLAVONE; BUCLADESINE; CYTOCHROME P450; DAIDZEIN; DOCEBENONE; FORSKOLIN; GENISTEIN; IBERIOTOXIN; INDOMETACIN; ISOPRENALINE; MEPACRINE; METYRAPONE; PHOSPHODIESTERASE; POTASSIUM CHANNEL; THEOPHYLLINE;

ANIMAL TISSUE; AORTA; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR RING; VASODILATATION;

ADRENERGIC BETA-AGONISTS; ANIMALS; AORTA; BENZOFLAVONES; BUCLADESINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENZYME INHIBITORS; FORSKOLIN; GENISTEIN; ISOPROTERENOL; MALE; METHOXSALEN; MUSCLE RELAXATION; PHOSPHODIESTERASE INHIBITORS; QUINACRINE; RATS; RATS, WISTAR; THEOPHYLLINE;

EID: 0032764925     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(99)00011-7     Document Type: Article

References (35)

1. Abebe W., Agrawal D.K. Role of tyrosine kinases in norepinephrine-induced contraction of vascular smooth muscle. J Cardiovasc Pharmacol. 26:1995;153-159.
2. Adeagbo A.S.O., Breen C.A., Cutz E., Lees J.G., Olley P.M., Coceani F. Lamb ductus venosus. Evidence of a cytochrome P-450 mechanism in its contractile tension J Pharmacol Exp Ther. 252:1990;875-879.
3. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem. 262:1987;5592-5595.
4. Alkayed N.J., Birks E.K., Hudetz A.G., Roman R.J., Henderson L., Harder D.R. Inhibition of brain P-450 archidonic acid epoxygenase decreases baseline cerebral blood flow. Am J Physiol. 271:1996;H1541-H1546.
5. Bennet B.M., Molina C.R., Waldman S.A., Murad F. Cyclic nucleotides and protein phosphorylation in vascular smooth muscle relaxation. Sperelakis N. Physiology and pathophysiology of the heart. 1989;825-846 Kluwer Academic, Boston.
6. + channels by protein kinase A and phosphatase inhibitors. Am J Physiol. 261:1991;C387-C392.
7. Coceani F., Breen C.A., Lees J.G., Galck J.R., Olley P.M. Further evidence implicating a cytochrome P-450-mediated reaction in the contractile tension of the lamb ductus arteriosus. Circ Res. 62:1988;471-477.
8. Di Salvo J., Semenchuk L., Kolquist K., Pfitzer G. Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle. Biochem Biophys Res Commun. 190:1993;968-974.
9. Escalante B., Sessa W.C., Falck J.R., Yadagiri P., Schwartzman M.L. Vasoactivity of 2-hydroxyeicosatetraenoic acid is dependent on metabolism by cyclooxygenase. J Pharmacol Exp Ther. 248:1989;229-232.
10. Feinstein D.L., Galea E., Cermak J., Chugh P., Lyandvert L., Reis D.J. Nitric oxide synthase expression in glial cells. Suppression by tyrosine kinase inhibitors J Neurochem. 62:1994;811-814.
11. Galvez A., Gimenez-Gallego G., Reuben J.P., Roy-Contancin L., Feigenbaum P., Kaczorowski G., Garcia M.L. Purification and characterization of a unique, potent, peptidyl probe for the high conductance calcium-activated potassium channel from venom of the scorpion Buthus tamulus. J Biol Chem. 265:1990;11083-11090.
12. Gebremedhin D., Ma Y.-H., Falck J.R., Roman R.J., VanRollins M., Harder D.R. Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle. Am J Physiol. 263:1992;H519-H525.
13. Harder D.R., Cambell W.B., Roman R.J. Role of cytochrome P-450 enzymes and metabolites of archidonic acid in the control vascular tone. J Vasc Res. 32:1995;79-92.
14. Harder D.R., Lange A.R., Gebremedhin D., Birks E.K., Roman R.J. Cytochrome P450 metabolites of archidonic acid as intracellular signaling molecules in vascular tissues. J Vasc Res. 34:1997;237-243.
15. Hecker M., Bara A.T., Bauersachs J., Busse R. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived archidonic acid metabolite in mammals. J Physiol. 481:1994;407-414.
16. Hildebrandt A.G. The binding of metyrapone to cytochrome P-450 and its inhibitory actions on microcosmal hepatic mixed function oxidation reactions. Biochem Soc Symp. 34:1972;79-102.
17. Hiramatsu T., Kume H., Kotolikoff M.I., Takagi K. Role of calcium-activated potassium channels in the relaxation of tracheal smooth muscles by forskolin. Clin Exp Pharmacol Physiol. 21:1994;367-375.
18. Ho A.K., Wiest R., Ogiwara T., Mudoch G., Chik C.L. Potentiation of agonist-stimulated cyclic AMP accumulation by tyrosine kinase inhibitors in rat pinealocytes. J Neurochem. 65:1995;1597-1603.
19. Imig D.J., Zou A.-P., Stec D.E., Harder D.R., Falck J.R., Roman R.J. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am J Physiol. 270:1996;R217-R227.
20. 2-Adrenoceptor-mediated vasoconstriction requires a tyrosine kinase. Eur J Pharmacol. 277:1995;29-34.
21. Ca channels in airway smooth muscle by cAMP dependent and independent mechanisms. J Clin Invest. 93:1994;371-379.
22. Ma, Y.-H., Gebremedhim, D., Schwartzman, M.L., Falck, J.R., Clark, J.E., Masters, B.S., Harder, D.R., Roman, R.J., 1993. 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ Res 72, 116-136.
23. Marczin N., Papapetropoulos A., Catravas J.D. Tyrosine kinase inhibitors suppress endotoxin- and IL-1β-induced NO synthesis in aortic smooth muscle cells. Am J Physiol. 265:1993;H1014-H1018.
24. Miura M., Belvisi M.G., Stretton C.D., Yacoub M.H., Barnes P.J. Role of potassium channels in bronchodilator responses in human airways. Am Rev Respir Dis. 146:1992;132-136.
25. Moritoki H., Hisayama T., Takeuchi S., Kondoh W., Takeji Y. Possible involvement of tyrosine kinase in the LPS-promoted initiation of L-arginine-induced relaxation of rat aorta mediated by induction of NO synthase. Life Sci. 57:1995;125-130.
26. Pinto A., Abraham N.G., Mullane K.M. Cytochrome P-450-dependent monooxygenase activity and endothelial-dependent relaxations induced by archidonic acid. J Pharmacol Exp Ther. 236:1986;445-451.
27. Rasmussen H. The calcium messenger system. New Engl J Med. 314:1986;1094-1101.
28. 2 and epoxyeicosatrienoic acid in relaxation of bovine coronary arteries to archidonic acid. Am J Physiol. 264:1993;H327-H335.
29. Sadoshima J., Akaike N., Kanaide H., Nakamura M. Cyclic AMP modulates Ca-activated K channel in cultured smooth muscle cells of rat aortas. Am J Physiol. 255:1988;H754-H759.
30. Saifeddine M., Laniyonu A., Yang S.-G., Hollenberg M.D. Tyrosine kinase inhibitors and the contractile action of angiotensin-II in vascular tissue. Pharmacol Commun. 1:1992;177-184.
31. Sauro M.D., Thomas B. Tyrosine attenuates platelet-derived growth factor-induced constriction in aortic smooth muscle through inhibition of protein tyrosine kinase(s). J Pharmacol Exp Ther. 267:1993;1119-1125.
32. Schenkman J.B., Sligar S.G., Cinti D.L. Substrate interaction with cytochrome P-450. Int Encycl Pharmacol Ther. 108:1982;587-615.
33. + channel may involve a G-protein dependent mechanism. Faseb J. 11:1997;A503.
34. - secretion across canine tracheal epithelium through cyclo-oxygenase stimulation and cAMP production. Acta Physiol Scand. 145:1992;1-6.
35. + channel in renal arterioles. Am J Physiol. 270:1996;R228-R237.